1. YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
   Ganglin Su et al, 2021, Frontiers in Pharmacology CrossRef
2. Expression and Prognostic Role of E2F2 in Hepatocellular Carcinoma
   Shen Shen et al, 2021, International Journal of General Medicine CrossRef
3. A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients
   Chao Ma, 2024, Current Medicinal Chemistry CrossRef
4. Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
   Pengpeng Zhang et al, 2023, Frontiers in Oncology CrossRef
5. The E2F family: a ray of dawn in cardiomyopathy
   Jinwen Wei et al, 2024, Molecular and Cellular Biochemistry CrossRef
6. Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq
   Pengpeng Zhang et al, 2023, Frontiers in Immunology CrossRef
7. The regulatory network for the G1/S transition in Saccharomyces cerevisiae promotes the understanding of cancer developmental mechanisms
   Cheng Zhou et al, 2024, Biotechnology & Biotechnological Equipment CrossRef
8. How cancer cells remodel lipid metabolism: strategies targeting transcription factors
   Do-Won Jeong et al, 2021, Lipids in Health and Disease CrossRef
9. Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma
   Shengqiang Zhang et al, 2021, Aging CrossRef
10. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma
    Xiangyu Zheng et al, 2020, BioMed Research International CrossRef
11. Profiling mRNA and miRNA expression variations associated with cyclin-dependent kinase pathway in the low-grade luminal early breast cancer
    Amir Mahdi Khamaneh et al, 2024, Journal of Applied Genetics CrossRef
12. Study of the Role of E2F1 and TMEM132A in Prostate Cancer Development
    Ying Wang et al, 2024, Frontiers in Bioscience-Landmark CrossRef
13. By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma
    Pengpeng Zhang et al, 2023, Frontiers in Immunology CrossRef
14. Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer
    Shengbin Pei et al, 2023, Frontiers in Endocrinology CrossRef